|
National Stock Number(NSN): 6505-01-377-9373 (6505013779373, 013779373)
| NIIN: |
01-377-9373 |
Item Name: |
CEFADROXIL FOR ORAL SUSPENSION |
INC: |
42098
|
| FSC: |
6505
|
Assignment Date: |
Aug-04-1993 |
CRIT: |
X |
IIG: |
42098 |
| ISC: |
2 |
Date Standardized: |
Aug-04-1993 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Sep-01-2005 |
PMIC: |
A |
FIIG: |
A34300 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
DURICEF |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
L93-204 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00015-7283-40 |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
5 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00015-7283-40 |
97374
|
BRISTOL-MYERS SQUIBB CO MEAD JOHNSON NUTRITIONALS MEAD JOHNSON AND CO |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC00087-0786-41 |
29398
|
MEAD JOHNSON & COMPANY, LLC |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
ULTRACEF |
97374
|
BRISTOL-MYERS SQUIBB CO MEAD JOHNSON NUTRITIONALS MEAD JOHNSON AND CO |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
U |
1 |
A |
$6.19 |
BT |
|
C2201X- |
Aug-01-1993 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$6.19 |
BT |
|
------- |
Jun-01-1995 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$6.19 |
BT |
|
9L----- |
Jun-01-2004 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$6.19 |
BT |
|
------- |
Aug-01-1993 |
H |
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AGXW |
PHYSICAL FORM |
POWDER |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
125.000 MILLIGRAMS CEFADROXIL PER 5 MILLILITERS OF RECONSTITUTED SUSPENSION |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
100.000 MILLILITERS AFTER RECONSTITUTION |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
CEFADROXIL FOR ORAL SUSPENSION 125MG/5ML POWDER FORM 100ML |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Mar-01-2005 |
3 |
H |
|
|
|
|
| FSKX |
|
Mar-01-2005 |
3 |
H |
|
|
|
|
| N9LM |
|
Mar-01-2005 |
3 |
H |
|
|
|
|
| Source: |
P |
Primary Inventory Control Activity (PICA) |
Status: |
H |
| Pri/Sec ICC: |
P |
Container NSN: |
|
Category Code: |
ZZZZ |
| Lvl A Pkg Req: |
Z |
Unit Pack Size: |
|
Pres Material: |
ZZ |
| Lvl B Pkg Req: |
Z |
Unit Pack Weight: |
0.0 |
Pres Method: |
ZZ |
| Lvl C Pkg Req: |
|
Unit Pack Cube: |
0.000 |
Wrapping Mat: |
ZZ |
| Opt Proc Ind: |
M |
Unpkg Item Dims: |
|
Spec Marking: |
ZZ |
| Container FSC: |
|
SPI Number: |
MPPWN00001 |
SPI Revision: |
|
| Unpkg Weight: |
|
SPI Date: |
Mar-30-1988 |
Pkg Design Activity: |
89875
|
| Inter Container Qty: |
|
Inter Container Code: |
|
Clean/Dry Procedure: |
Z |
| Unit Container: |
ZZ |
Item Type Storage: |
|
Unit Container Level: |
|
| |
|
Cush/Dun Material: |
ZZ |
Cush/Dun Thickness: |
Z |
|